Hangzhou release urgent notice inactive one the intersection of intravenous injection and the intersection of people and immunoglobulin (Ig)

Hangzhou release urgent notice inactive one the intersection of intravenous injection and the intersection of people and immunoglobulin (Ig)
Hangzhou release urgent notice inactive one the intersection of intravenous injection and the intersection of people and immunoglobulin (Ig)
Today, municipal food medicines in Hangzhou supervise the administration bureau releasing the urgent notice, require all medicines of the whole city to manage, medical organization applying unit must stop, sell and use, label lot number that Co., Ltd. produce 20070514 the intersection of intravenous injection and people for the intersection of Jiangxi and learned bio-pharmaceuticals immediately Immunoglobulin (Ig) (pH4) . According to the report of monitoring center of bad reaction of national medicines, the serious bad reaction appears after some hospital use of Jiangxi in this medicines. In order to guarantee the public uses the medicine security, national food medicines supervise the administration bureau, Ministry of Public Health determines to delay labelling sale and use of all lot number intravenous injection people immunoglobulin (Ig) produced for the learned bio-pharmaceuticals Co., Ltd. of Jiangxi. Medicines of the lot number of this problem are in course of investigating and handling at present.


|